Are you a professional? Activate your profile

Are you already registered? Access Forgot your password?

Financial advisors
Calculation tools
- Calculates the risk and return of a securities portfolio
- Calculate your supplementary pension
News from the UK Stock Exchange

Funds / ETFs / Stock Ranking
Learn about finance
- Financial glossary
- Learning to invest
  The most important concepts of finance
Study Office
- Asset allocation
- Finance app ranking
About us

Biomerica Inc. - news published 141 - readings 2.965

BACK

Biomerica Inc.

Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn’s Disease and Ulcerative Colitis

Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative Colitis Significant Milestone: Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union standards and allowing sales of the products in the EU Focus on Precision Medicine: Certification c ...

26.02.2025

Biomerica Inc.

Biomerica’s inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

Biomerica's inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal inFoods IBS Provides Personalized Diet Therapy for Patients Suffering with Irritable Bowel Syndrome (IBS) Research Finds Patients Following a Personalized Diet Therapy Created with inFoods ® IBS, Experienced Reduced Abdominal Pain and Bloating IRVINE, Ca ...

19.02.2025

Biomerica Inc.

Biomerica Reports Second Quarter Fiscal 2025 Financial Results

- Total Revenue Increases 5% Year-Over-Year - Achieves Sustained Revenue Growth, Improved Gross Margins, and Significant Cost Savings IRVINE, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the "Company") a global provider of advanced medical diagnostic and therapeutic products today reported financial results for the second quarter of fisc ...

15.01.2025

Biomerica Inc.

Quarterly Report for Quarter Ending NOVEMBER 30, 2024 (Form 10-Q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED NOVEMBER 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37863 BIOMERICA, INC. (Exact nam ...

14.01.2025

Biomerica Inc.

Initial Registration Statement for Employee Benefit Plan (Form S-8)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT Under THE SECURITIES ACT OF 1933 BIOMERICA, INC. (Exact name of Registrant as specified in its charter) Delaware 95-2645573 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 17571 Von Karman Avenue, Irvine, California 92614 ( ...

20.12.2024

Biomerica Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Ownership Submission FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. UNITED STATES SECURITIES A ...

18.12.2024

Biomerica Inc.

Statement of Changes in Beneficial Ownership (Form 4)

18.12.2024

Biomerica Inc.

Statement of Changes in Beneficial Ownership (Form 4)

18.12.2024

Biomerica Inc.

Statement of Changes in Beneficial Ownership (Form 4)

18.12.2024

Biomerica Inc.

Statement of Changes in Beneficial Ownership (Form 4)

18.12.2024

Biomerica Inc.

Statement of Changes in Beneficial Ownership (Form 4)

18.12.2024

Biomerica Inc.

Proxy Results Form 8 K

Item 5.07 Submission of Matters to a Vote of Security Holders. Biomerica, Inc. (the "Company") held its 2024 Annual Meeting of Stockholders (the "2024 Annual Meeting") on December 13, 2024, at its corporate headquarters in Irvine, California. As of October 16, 2024, the record date for the 2024 Annual Meeting, the Company had 16,821,646 shares of common sto ...

17.12.2024

Biomerica Inc.

Initial Registration Statement for Employee Benefit Plan Form S 8

25.11.2024

Biomerica Inc.

Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn’s Disease, and Ulcerative Colitis

Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis New patents position Biomerica to address multi-billion-dollar markets in Europe, including GERD ($4 billion+), Crohn's Disease ($2.5 billion+), and Ulcerative Colitis ($1.9 billion+) The company received three notices of allowance in countries wi ...

21.11.2024

Biomerica Inc.

Investor Presentation

Investor Presentation N o v e m b e r 2 0 2 4 Forward-Looking Statement The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Certain information included in this presentation (as well as information included in oral statements or other written statements made or to be made by Biomerica) contains statements that ...

12.11.2024

Biomerica Inc. - news published 141 - readings 2.965

Biomerica Inc.

Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn’s Disease and Ulcerative Colitis

Biomerica Inc.

Biomerica’s inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

Biomerica Inc.

Biomerica Reports Second Quarter Fiscal 2025 Financial Results

Biomerica Inc.

Quarterly Report for Quarter Ending NOVEMBER 30, 2024 (Form 10-Q)

Biomerica Inc.

Initial Registration Statement for Employee Benefit Plan (Form S-8)

Biomerica Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Biomerica Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Biomerica Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Biomerica Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Biomerica Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Biomerica Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Biomerica Inc.

Proxy Results Form 8 K

Biomerica Inc.

Initial Registration Statement for Employee Benefit Plan Form S 8

Biomerica Inc.

Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn’s Disease, and Ulcerative Colitis

Biomerica Inc.

Investor Presentation

You have reached the maximum number of requests. You can no longer send.

Become Member

€2,99per month

Become Member

€2,99per month

You have reached the maximum
number of requests.
You can no longer send.

Become
Member

Become
Member